Physician profile
Michael Polcino
NPI 1922180280
$2,608.65
in general payments reported to CMS, 2019-2025
18 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $52.77 · 2021: $154 · 2022: $319 · 2023: $1,561 · 2024: $108 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,400 · Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,400.00 |
| Food and Beverage | $461.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $1,400.00 | 2023 | |
| Exeltis, USA INC. | $299.16 | 2021-2025 | Slynd |
| Lupin INC. | $155.15 | 2019-2021 | |
| Aspira Women'S Health INC | $150.07 | 2022 | |
| Abbvie INC. | $148.14 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $78.05 | 2025 | |
| Lilly USA, LLC | $73.07 | 2025 | Mounjaro, Zepbound |
| Sumitomo Pharma America, INC. | $53.98 | 2023 | Myfembree |
| Evofem Biosciences, INC. | $38.53 | 2022 | |
| Therapeuticsmd, INC. | $35.95 | 2019-2021 | |
| Scynexis, INC. | $30.93 | 2022 | |
| Biogen, INC. | $26.96 | 2024 | |
| Hologic Sales and Service, LLC | $24.75 | 2023 | Thinprep 2000 Processor |
| Astellas Pharma US INC | $22.36 | 2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $21.32 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $20.14 | 2023 | Wegovy |
| Organon LLC | $18.24 | 2024 | |
| Avion Pharmaceuticals | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Polcino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.